Are you passionate about the fascinating world of gut microbiota and its impact on human health? This is your opportunity to immerse yourself in cutting-edge research, engage with renowned experts, and be part of groundbreaking discussions that shape the future of healthcare!
Our R&D Scientist – Health & Nutrition Business Unit, Valentina Taverniti will be addressing the conference on the 22nd during Gut-Health Axis session with the scientific review “Gut microbiota modulation by probiotics improves inflammaging”.
The health benefits of probiotics are not limited to the gut. Among the many mechanisms on how these systemic health benefits arise, the modulation of the gut microbiota composition through probiotic intake is an important one, as it can impact the metabolic milieu in the gut, and thus regulate specific host cell pathways and responses. In this context, we present a clinical study focused on the use of a well-characterized combination of probiotic strains Lacticaseibacillus rhamnosus IMC 501® and Lacticaseibacillus paracasei IMC 502®, named SYNBIO®, that can improve inflammaging and the nutritional status of the elderly.
Save the date and secure your spot at IPC2023!
Don't miss out on the chance to be at the forefront of scientific discovery and innovation in the realm of probiotics, prebiotics, and gut microbiota research.